Abstract

ObjectivesTo develop a radiomics signature for predicting surgical portal vein-superior mesenteric vein (PV-SMV) in patients with pancreatic ductal adenocarcinoma (PDAC) and measure the effect of providing the predictions of radiomics signature to radiologists with different diagnostic experiences during imaging interpretation.MethodsBetween February 2008 and June 2020, 146 patients with PDAC in pancreatic head or uncinate process from two institutions were retrospectively included and randomly split into a training (n = 88) and a validation (n =58) cohort. Intraoperative vascular exploration findings were used to identify surgical PV-SMV invasion. Radiomics features were extracted from the portal venous phase CT images. Radiomics signature was built with a linear elastic-net regression model. Area under receiver operating characteristic curve (AUC) of the radiomics signature was calculated. A senior and a junior radiologist independently review CT scans and made the diagnosis for PV-SMV invasion both with and without radiomics score (Radscore) assistance. A 2-sided Pearson’s chi-squared test was conducted to evaluate whether there was a difference in sensitivity, specificity, and accuracy between the radiomics signature and the unassisted radiologists. To assess the incremental value of providing Radscore predictions to the radiologists, we compared the performance between unassisted evaluation and Radscore-assisted evaluation by using the McNemar test.ResultsNumbers of patients identified as presence of surgical PV-SMV invasion were 33 (37.5%) and 19 (32.8%) in the training and validation cohort, respectively. The radiomics signature achieved an AUC of 0.848 (95% confidence interval, 0.724–0.971) in the validation cohort and had a comparable sensitivity, specificity, and accuracy as the senior radiologist in predicting PV-SMV invasion (all p-values > 0.05). Providing predictions of radiomics signature increased both radiologists’ sensitivity in identifying PV-SMV invasion, while only the increase of the junior radiologist was significant (63.2 vs 89.5%, p-value = 0.025) instead of the senior radiologist (73.7 vs 89.5%, p-value = 0.08). Both radiologists’ accuracy had no significant increase when provided radiomics signature assistance (both p-values > 0.05).ConclusionsThe radiomics signature can predict surgical PV-SMV invasion in patients with PDAC and may have incremental value to the diagnostic performance of radiologists during imaging interpretation.

Highlights

  • Pancreatic ductal adenocarcinoma (PDAC) is a lethal disease, and the five-year survival rate is lower than 8% [1,2,3]

  • The ability of the radiomics signature to discriminate portal vein-superior mesenteric vein (PV-SMV) invasion was shown to have an area under receiver operating characteristic curve (AUC) of 0.871 [95% confidence interval (CI) 0.795–0.946] in the training cohort and 0.848 in the validation cohort (Figure 3A)

  • We developed a Radscore on presurgical pancreatic enhanced CT in classifying surgical PV-SMV invasion of PDAC in the pancreatic head or uncinate process

Read more

Summary

Introduction

Pancreatic ductal adenocarcinoma (PDAC) is a lethal disease, and the five-year survival rate is lower than 8% [1,2,3]. Regarding patients with peripancreatic arterial involvement, upfront surgery is known to be associated with a low resection rate and a deteriorated long-term survival [4, 5]. For patients with isolated peripancreatic venous [portal vein-superior mesenteric vein (PV-SMV)] involvement, long-term survival after extended pancreaticoduodenectomy (PD) with venous resection may be comparable to that achieved by standard PD without venous resection [6,7,8]. Preoperative knowledge of PV-SMV invasion status can promote adequate preoperative preparation, which may mitigate the positive margins associated with unplanned PV-SMV resection, decrease unresectable events due to the inexperience of extended PD, and reduce surgery-related complications [6,7,8, 10]

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call